Local News: Jerome, AZ 

 | 

Sign Up

 | 

Sign In

Advertisment

Cell Therapeutics

Cell Therapeutics News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Cell Therapeutics News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Cell Therapeutics News

News on Cell Therapeutics continually updated from thousands of sources around the net.

Thursday Dec 24 | TheStreet.com

Biotech Stock Mailbag: Year in Review

After re-reading all of the Biotech Stock Mailbag columns published in 2009, it's quite clear I wrote often about Cell Therapeutics and Hemispherx Biopharma .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Business News

Tue Dec 22, 2009

M2.com

Sign Up For Our Free Newsletter!! AGRT,ACTG,ZAGG,SNTS,CTIC,BLDP

STOCK MARKETING INC PRESENTS : AGR Tools, Inc., Acacia Research Corp., Zagg, Inc., Santarus, Inc., Cell Therapeutics, Inc., Ballard Power Systems, Inc.

Comment?

Related Topix: Scientific Instruments, Semiconductors, Acacia Research, Financial Services, Electronics, Investment Services, Marketing, Biotech, Medicine, Healthcare Industry

The South Mississippi Sun Herald

Cell Therapeutics Commits to PhRMA's Code on Interactions With Healthcare Professionals

Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's "Code on Interactions with Healthcare Professionals, revised July 2008" . Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lymphoma, Health, Healthcare Law, Law, Food and Drug Administration

Mon Dec 21, 2009

The South Mississippi Sun Herald

European Medicines Agency Grants Cell Therapeutics Orphan Drug...

Cell Therapeutics, Inc. announced today that the European Medicines Agency has granted pixantrone orphan drug designation for the treatment of DLBCL which accounts for about 80% of aggressive non-Hodgkin's lymphoma.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lymphoma, Health, Marketing, Healthcare Law, Law, Food and Drug Administration

Sat Dec 19, 2009

Earth Times

Top Gainers among Biotechnology Stocks were CTIC, CELG, VICL

Dallas, TX - Cell Therapeutics, Inc. surged 8.57% to $1.14 on 47.57 million shares.

1 comment

Related Topix: Biotech, Medicine, Healthcare Industry, Dallas, TX, Celgene, Leukemia, Health, Vical

Fri Dec 18, 2009

Seattle Post-Intelligencer

Xconomy: CTI Heading to FDA Panel

Cell Therapeutics , the Seattle-based developer of pixantrone for non-Hodgkin's lymphoma, said today that the experimental treatment will be reviewed by an FDA advisory panel on February 10.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lymphoma, Health

Thu Dec 17, 2009

The South Mississippi Sun Herald

Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee...

Cell Therapeutics, Inc. announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee will review the New Drug Application for pixantrone for the treatment of relapsed/refractory aggressive non-Hodgkin's lymphoma .

Comment?

Related Topix: Food and Drug Administration, Healthcare Law, Law, Biotech, Medicine, Healthcare Industry, Oncologic, Startups, Lymphoma, Health, Oncology

Wed Dec 16, 2009

Motley Fool

Why You Should Ignore Everyone's Predictions

It's the most wonderful time of the year. That's right -- it's that time when everyone on Wall Street comes out to make their market predictions for the year ahead.

Comment?

Related Topix: 9, Financial Markets, Biotech, Medicine, Healthcare Industry, Insurance, Conseco, Human Genome Sciences

TheStreet.com

Cell Therapeutics Gets FDA Panel for Lymphoma Drug: BioBuzz

Cell Therapeutics will be bringing its lymphoma drug pixantrone in front of a Food and Drug Administration advisory committee meeting in February, according to a newly published notice in the Federal Register.

Comment?

Related Topix: Food and Drug Administration, Lymphoma, Biotech, Medicine, Healthcare Industry

Tue Dec 08, 2009

TheStreet.com

Cell Therapeutics on Dilution Watch: BioBuzz

CEO Jim Bianco is on the road again -- and he has Rodman & Renshaw bankers in tow.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Investment Banking, Financial Services, Food and Drug Administration, Business News

Mon Dec 07, 2009

The South Mississippi Sun Herald

Pixantrone Produces 250% Relative Improvement in 1 Year Progression...

Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology Annual Meeting updated results from the pivotal phase III EXTEND clinical trial of pixantrone in relapsed or refractory, aggressive non-Hodgkin's lymphoma patients who have ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lymphoma, Health

Tue Dec 01, 2009

American Chronicle

Updates for Cell Therapeutics

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, SanofiSynthlabo, Cypress Bioscience, Opinion

Sun Nov 29, 2009

The South Mississippi Sun Herald

New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates,...

Cell Therapeutics, Inc. announced today that its new class of platinum-based anti-tumor compounds, termed bis-platinates, demonstrated a stronger anti-tumor potency and activity compared to currently available platinum-based compounds as well as the ability to overcome cisplatin-resistance in cancer cell lines.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Nov 24, 2009

Earth Times

DAILY customizes Rigid UHF tag for Industrial Applications

DAILY's rigid UHF tag is specially designed for Industrial Applications, since it is extremely resistant to harsh environment, including metallic and moist conditions.

Comment?

Related Topix: Science / Technology, RFID News, ISO 9000, Biotech, Medicine, Healthcare Industry

Mon Nov 23, 2009

Earth Times

Free Wondreshare spyware removal - protect PC agianst spyware, trojan virus and slow performance

November 20th, 2009 -Wondershare Software Co., Ltd, the world leading consuming software provider, announces a new product release----Wondershare Spyware Removal on its system utility official website .

Comment?

Related Topix: Spyware, Science / Technology, PC, Computers, IBM, Biotech, Medicine, Healthcare Industry

Thu Nov 19, 2009

PharmaGossip

"Grease the skids" for whistleblowing

A federal appeals court has ruled that Cell Therapeutics can pursue a claim for nearly $23 million against a former consultant that advised it to market a drug off-label, adding a whole new wrinkle to whistleblower lawsuits.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Nov 18, 2009

Hampton Roads Daily Press

Federal appeals court: Seattle biotech can pursue $23 million claim against former consultant

Seattle biotechnology firm Cell Therapeutics Inc. can pursue claims for nearly $23 million against a former consultant, a federal appeals court ruled Wednesday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, US News, Ninth Circuit Court of Appeals, Food and Drug Administration

Mon Nov 16, 2009

TheStreet.com

Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz

Christmas and Hanukah came early this year for executives and directors at Cell Therapeutics .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Business News

Sun Nov 08, 2009

GuruFocus.com

Cell Therapeutics Inc. Reports Operating Results

Cell Therapeutics Inc. filed Quarterly Report for the period ended 2009-09-30. Cell Therapeutic developing acquiring and commercializing novel treatments for cancer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology, Healthcare Law, Law

Fri Nov 06, 2009

TheStreet.com

Oculus, Bianco and Cel-Sci Oh My!: BioBuzz

A few fun tidbits for a Fall Friday: Uh-oh, Oculus Innovative Sciences ! Where is all that pent-up demand for the diluted bleach that the company peddles as Microcyn? The company announced results for the fiscal second quarter last night, with Microcyn sales of $1.4 million, down 13% sequentially.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, H1N1 Influenza / Swine Flu, Health

Jerome Jobs

Also on Topix